Management of Drug-Drug Interactions Between Long-Acting Cabotegravir and Rilpivirine and Comedications With Inducing Properties: A Modeling Study

BACKGROUND: Long-acting (LA) intramuscular cabotegravir and rilpivirine are prone to drug-drug interactions (DDI). However, given the long dosing interval, the conduct of clinical DDIs studies with LA antiretrovirals is challenging. We performed virtual clinical DDI studies using physiologically bas...

Descripción completa

Detalles Bibliográficos
Autores principales: Bettonte, Sara, Berton, Mattia, Stader, Felix, Battegay, Manuel, Marzolini, Catia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Major Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10069847/
https://www.ncbi.nlm.nih.gov/pubmed/36377436
http://dx.doi.org/10.1093/cid/ciac901

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10069847/
https://www.ncbi.nlm.nih.gov/pubmed/36377436
http://dx.doi.org/10.1093/cid/ciac901

Ejemplares similares